Target Audience
This activity is intended for medical professionals who have a clinical interest related to disparities and diversity in the context of clinical trial research.

Learning Objectives
After completing this activity, the participant should be better able to:

1.    Explain disparities in the context of clinical trial research.
2.    Explain diversity in the context of clinical trial research.
3.    Describe frameworks for understanding clinical trial diversification.
4.    Provide examples of successful strategies to increase diversity in clinical trial research in cancer.

Faculty

Electra D. Paskett, PhD Marion N. Rowley Professor of Cancer Research and Director The Division of Cancer Prevention and Control The College of Medicine The Ohio State University          Columbus, Ohio

American Association for Respiratory Care (AARC) Accreditation
AARC Designation Statement
This Non-traditional program has been approved for 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care; 9425 N. MacArthur Boulevard, Suite 100, Irving TX 75063 Course #193732000.

How to Obtain AARC / CRCE Credit
Attendees are expected to review all academic materials before attempting to apply for credit. Successful completion of this activity will lead to the issuance of a certificate for 1.0 contact hour of CRCE approved continuing education.

To receive credit, please follow these steps:

• Complete the online registration (registration is free).
• Review all of the academic materials provided. 
• Click on the CRCE link to apply for credit. 
• Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate. 
• Qualified applicants will be provided with an online (printable) CRCE certificate based on their attendance and satisfactory completion of this academic acitivity. 

Term Offering
This activity was released on February 2, 2025 and is valid for two years. Requests for credit must be made no later than February 2, 2027.